Clinical Trial Update: A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adriamycin/cyclophosphamide with G-CSF followed by paclitaxel as adjuvant therapy for high-risk stage II/III breast cancer that has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Filgrastim (filgrastim)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED